Fatal azathioprine toxicity

Affiliations

Case Reports

David Liew et al. Aust Prescr. 2017 Jun.

. 2017 Jun;40(3):109.

doi: 10.18773/austprescr.2017.035. Epub 2017 Jun 1.

No abstract available

Conflict of interest statement

David Liew is attending Editorial Executive Committee meetings as the clinical pharmacology registrar for Australian Prescriber in 2017.

1. Australian medicines handbook. Adelaide: Australian Medicines Handbook; 2017. https://amhonline.amh.net.au [cited 2017 May 1]
1. Lennard L, Cartwright CS, Wade R, Richards SM, Vora A. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia. Br J Clin Pharmacol 2013;76:125-36. https://doi.org/10.1111/bcp.1206610.1111/bcp.12066 - DOI - DOI - PMC - PubMed
1. Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW, et al. Clinical Pharmacogenetics Implementation Consortium Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther 2011;89:387-91. https://doi.org/10.1038/clpt.2010.32010.1038/clpt.2010.320 - DOI - DOI - PMC - PubMed
1. Ford LT, Berg JD. Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come. J Clin Pathol 2010;63:288-95. https://doi.org/10.1136/jcp.2009.06925210.1136/jcp.2009.069252 - DOI - DOI - PubMed